Evidence map›Paper›PMID 39691492›Full record

ArticleAIDS research and treatment2024

Evaluation of Treatment Outcomes Among Individuals on Highly Active Antiretroviral Therapy in KwaZulu-Natal, South Africa.

Tambwe Willy Muzumbukilwa, Riziki Ghislain Manimani, Aganze Gloire-Aime Mushebenge, Rajesh Vikram Vagiri, Manimbulu Nlooto

Abstract read
In one paragraph

Article in AIDS research and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tambwe Willy MuzumbukilwaDepartment of Pharmaceutical Sciences, Discipline of Pharmaceutical Sciences, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, University Road, Durban 4001, South Africa.ORCID https://orcid.org/0000-0001-8641-405X
Riziki Ghislain ManimaniDepartment of Internal Medicine, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.ORCID https://orcid.org/0000-0003-4053-0236
Aganze Gloire-Aime MushebengeDepartment of Pharmaceutical Sciences, Discipline of Pharmaceutical Sciences, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, University Road, Durban 4001, South Africa.
Rajesh Vikram VagiriDepartment of Pharmaceutical Sciences, Discipline of Pharmaceutical Sciences, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, University Road, Durban 4001, South Africa.
Manimbulu NlootoDepartment of Pharmaceutical Sciences, Discipline of Pharmaceutical Sciences, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, University Road, Durban 4001, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite access to antiretroviral therapy (ART), South Africa has a high human immunodeficiency virus (HIV) burden. Treatment outcomes among individuals on highly active ART (HAART) in KwaZulu-Natal, with a higher incidence of HIV, are not fully known. This study evaluated the impact of HAART outcomes and identified and analyzed the factors associated with the outcomes in people living with HIV and AIDS (PLWHA) in the high-incidence region of KwaZulu-Natal Province, South Africa. This retrospective medical record review was conducted at King Edward VIII Hospital in South Africa. Data analysis was performed using STATA software Version 18.0 and Microsoft Excel 2021. The estimates used were 95% confidence intervals, and a

Indexed as

HAARTHIV/AIDSKwaZulu-NatalPLWHAtreatment outcomes

Identifiers

PMID39691492
PMCPMC11651757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.